Drugs Made In America Acquisition Corp. (DMAAU) Current Assets (2024 - 2025)
Drugs Made In America Acquisition's (DMAAU) quarterly Current Assets came in at $12191.0 in Q4 2025, up 144.26% YoY from $4991.0 in Q4 2024, and down 56.76% on a QoQ basis from $28196.0 in Q3 2025.
Drugs Made In America Acquisition Corp. (DMAAU) Current Assets (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMAAU) has 2 years of Current Assets data on file, last reported at $12191.0 in Q4 2025.
- Quarterly Current Assets rose 144.26% year-over-year to $12191.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12191.0 (up 144.26% YoY) and the FY2025 annual result came in at $12191.0, up 144.26% from the prior year.
- Current Assets retreated to $12191.0 in Q4 2025, from $28196.0 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $71019.0 in Q1 2025 to a low of $4991.0 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12,191.00 |
| Sep 30, 2025 | 28,196.00 |
| Jun 30, 2025 | 49,726.00 |
| Mar 31, 2025 | 71,019.00 |
| Dec 31, 2024 | 4,991.00 |